| Literature DB >> 27002148 |
Nathalie Sakakini1, Laurent Turchi2, Aurélie Bergon3, Hélène Holota3, Samah Rekima2, Fabrice Lopez3, Philipe Paquis4, Fabien Almairac4, Denys Fontaine5, Nathalie Baeza-Kallee6, Ellen Van Obberghen-Schilling2, Marie-Pierre Junier7, Hervé Chneiweiss7, Dominique Figarella-Branger8, Fanny Burel-Vandenbos9, Jean Imbert10, Thierry Virolle11.
Abstract
Glioblastomas are the most common primary brain tumors, highly vascularized, infiltrating, and resistant to current therapies. This cancer leads to a fatal outcome in less than 18 months. The aggressive behavior of glioblastomas, including resistance to current treatments and tumor recurrence, has been attributed to glioma stemlike/progenitor cells. The transcription factor EGR1 (early growth response 1), a member of a zinc finger transcription factor family, has been described as tumor suppressor in gliomas when ectopically overexpressed. Although EGR1 expression in human glioblastomas has been associated with patient survival, its precise location in tumor territories as well as its contribution to glioblastoma progression remain elusive. In the present study, we show that EGR1-expressing cells are more frequent in high grade gliomas where the nuclear expression of EGR1 is restricted to proliferating/progenitor cells. We show in primary cultures of glioma stemlike cells that EGR1 contributes to stemness marker expression and proliferation by orchestrating a PDGFA-dependent growth-stimulatory loop. In addition, we demonstrate that EGR1 acts as a positive regulator of several important genes, including SHH, GLI1, GLI2, and PDGFA, previously linked to the maintenance and proliferation of glioma stemlike cells.Entities:
Keywords: cancer biology; cancer stem cells; cell proliferation; cell signaling; transcription factor
Mesh:
Substances:
Year: 2016 PMID: 27002148 PMCID: PMC4865916 DOI: 10.1074/jbc.M116.720698
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157